| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9402686 | Journal of Surgical Research | 2005 | 6 Pages |
Abstract
MIP-3α, through its CCR6 receptor, promotes tumor cell invasion by the up-regulation of MMP-9. Molecular based therapy aimed at the inhibition of MIP-3α activity through the CCR6 receptor may serve as a future target to prevent tumor cell invasion in pancreatic adenocarcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Amy S. M.D., Daniel M.D., Ph.D., Troy F. M.D., Stephanie L. B.S., Thomas N. M.D., Ph.D.,